Nano Science and Technology Institute - NSTI  
Nano Science and Technology Institute   Home | Subscribe | Site Map  
  ABOUT | COURSES | EVENTS | PUBLICATIONS | LEADERSHIP | OUTREACH | NEWS | PRESS | JOBS | Nanotechnology Solutions
px
px fade_top
Publications
Nanotech 2008 CDROM
Nanotech 2007 CDROM
Nanotech 2006 CDROM
Nanotech 2005 CDROM
Nanotech 2004 CDROM
3 CDROM Special Offer
Nanotech 2008 Vol. 1
Nanotech 2008 Vol. 2
Nanotech 2008 Vol. 3
Nanotech 2007 Vol. 1
Nanotech 2007 Vol. 2
Nanotech 2007 Vol. 3
Nanotech 2007 Vol. 4
Nanotech 2006 Vol. 1
Nanotech 2006 Vol. 2
Nanotech 2006 Vol. 3
Nanotech 2005 Vol. 1
Nanotech 2005 Vol. 2
Nanotech 2005 Vol. 3
WCM 2005
Nanotech 2004 Vol. 1
Nanotech 2004 Vol. 2
Nanotech 2004 Vol. 3
Nanotech 2003 Vol. 1
Nanotech 2003 Vol. 2
Nanotech 2003 Vol. 3
Nanotech 2002 Vol. 1
Nanotech 2002 Vol. 2
Nanotech 2001 Vol. 1
Nanotech 2001 Vol. 2
MSM 2000
MSM 99
MSM 98
Index of Authors
Index of Keywords
Index of Affiliations
Library Request Form
Shopping Cart
Order Form
 
Publications Publications
Nanotech 2006 Vol. 2
p
 
Technical Proceedings of the 2006 NSTI Nanotechnology Conference and Trade Show, Volume 2
Nanotech 2006 Vol. 2
Technical Proceedings of the 2006 NSTI Nanotechnology Conference and Trade Show, Volume 2
 
Chapter 1: Cancer Nanotechnology
 

Rapid Detection of Multiple Myeloma using a microfluidic platform

Authors:G. Kaigala, J. VanDjinkin, B.J. Taylor, C.J. Backhouse and L.M. Pilarski
Affilation:University of Alberta, CA
Pages:49 - 52
Keywords:microfluidics, microchips, multiple myeloma, biomarkers, gene rearrangement
Abstract:MM has a unique molecular signature and is well suited as a model system for performing analysis on microchips. MM multiplex genetic analysis for clonotypic signatures and genetic abnormalities offers the possibility for genetic profiling and monitoring. Analysis of ex-vivo cancer cells is performed in an automated, rapid, low-volume (nL) regime, leading to accelerated thermal kinetics by the use of a microfluidic platform. Both genomic DNA and IgH VDJ transcripts amplified from individual cells were detectable on-chip with 50pL of product, which accounts for 0.001% of the amplified product from one individual MM cell or from groups of MM cells. PCR on a chip with cDNA template from one single MM cell amplified the t(4;14) signature. Microfluidic platforms developed here employ novel technology for large scale genetic screening of MM patients, enabling predictions of risk and stratification for treatment, based on the genetic signature of each cancer.
ISBN:0-9767985-7-3
Pages:893
Hardcopy:$185.00
 
Order:Mail/Fax Form
Special:3 CD Set — 15% off with Free Shipping
Up
nanoPRwire™
nanoPRwire
News Headlines
nano World news
 
 
 
 
px
© Nano Science and Technology Institute     About NSTI | Terms of Use | Privacy Policy | Contact